Expressions of PDGF-B and collagen type III in the remodeling of experimental saccular aneurysm in rats

Neurological Research

Volumn 30, Issue 6, 2008, Pages 632-638

  Liu, Bing ^a   Zhang, Jian Ning ^a   Pu, Pei Yu ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Collagen type III; Intracranial aneurysm; PDGF B; Rat; Vascular remodeling

Indexed keywords

COLLAGEN TYPE 3; MATRIX METALLOPROTEINASE; PLATELET DERIVED GROWTH FACTOR B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAROTID ARTERY BIFURCATION; CONTROLLED STUDY; FEMALE; HEMODYNAMIC STRESS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTIMA; MICROSURGERY; NONHUMAN; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; SACCULAR ANEURYSM;

ANALYSIS OF VARIANCE; ANIMALS; COLLAGEN TYPE III; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; INTRACRANIAL ANEURYSM; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, WISTAR;

EID: 47749147661     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/174313208X291595     Document Type: Article

References (48)

1. Rinkel GJ, Djibuti M, Algra A, et al. Prevalence and risk of rupture of intracranial aneurysms: A systematic review. Stroke 1998; 29: 251-256
2. Linn FHH, Rinkel GJE, Algra A, et al. Incidence of subarachnoid hemorrhage: Role of region, year and rate of computed tomography, a meta-analysis. Stroke 1996; 27: 625-629
3. Stehbens WE. Etiology of intracranial berry aneurysms. J Neurosurg 1989; 70: 823-831
4. Stehbens WE. Pathology and pathogenesis of intracranial berry aneurysms. Neurol Res 1990; 12: 29-34
5. Hashimoto T, Meng H, Young WL. Intracranial aneurysms: Links among inflammation, hemodynamics and vascular remodeling. Neurol Res 2006; 28: 372-380
6. Austin G, Fisher S, Dickson D, et al. The significance of the extracellular matrix in intracranial aneurysms. Ann Clin Lab Sci 1993; 23: 97-105
7. Futami K, Yamashita J, Tachibana O, et al. Immunohistochemical alterations of fibronectin during the formation and proliferative repair of experimental cerebral aneurysms in rats. Stroke 1995; 25: 1659-1664
8. Mimata C, Kitaoka M, Nagahiro S, et al. Differential distribution and expressions of collagens in the cerebral aneurysmal wall. Acta Neuropathol 1997; 94: 197-206
9. Gaetani P, Tartara F, Tanicioni F, et al. Deficiency of total collagen content and of deoxypyridinoline in intracranial aneurysm walls. FEBS Lett 1997 404:303-306
10. Gaetani P, Tartara F, Grazioli V, et al. Collagen cross-linkage, elastolytic and collagenolytic activities in cerebral aneurysms: A preliminary investigation. Life Sci 1998; 63: 285-292
11. Ferrans VJ. New insights into the world of matrix metalloproteinases. Circulation 2002; 105: 405-407
12. Kim SC, Singh M, Huang J, et al. Matrix metalloproteinase-9 in cerebral aneurysms. Neurosurgery 1997; 41: 642-647
13. Bruno G, Todor R, Lewis I, et al. Vascular extracellular matrix remodeling in cerebral aneurysms. J Neurosurg 1998; 89: 431-440
14. Linder V, Giachelli CM, Schwartz SM, et al. A subpopulation of smooth muscle cells in injured rat arteries expresses platelet-derived growth factor B chain mRNA. Circ Res 1995; 76: 951-957
15. Gull WM. Cases of aneurysm of the cerebral vessels. Guys Hosp Rep 1859; 5: 281-304
16. Schievink WI. Genetics of intracranial aneurysms. Neurosurgery 1997; 40: 651-663
17. Ruigrok YM, Rinkel GJ, Wijmenga C, et al. Genetics of intracranial aneurysms. Lancet Neurol 2005; 4: 179-189
18. Gieteling EW, Rinkel GJ. Characteristics of intracranial aneurysms and subarachnoid haemorrhage in patients with polycystic kidney disease. J Neurol 2003; 250: 418-423
19. Pepin M, Schwarze U, Super-Fuega A, et al. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med 2000; 342: 673-680
20. van den Berg JS, Limburg M, Hennekam RC. Is Marfan syndrome association with symptomatic intracranial aneurysm? Stroke 1996; 27: 10-12
21. Conway JE, Hutchins GM, Tamargo RJ. Lack of evidence for an association between neurofibromatosis type I and intracranial aneurysms: Autopsy study and review of the literature. Stroke 2001; 32: 2481
22. van den Berg JS, Pals G, Arwat F, et al. Type III collagen deficiency in saccular intracranial aneurysms: Defect in gene regulation? Stroke 1999; 30: 1628-1631
23. Kuivaniemi H, Prockop DJ, Nu Y, et al. Exclusion of mutations in the gene for type III collagen (COL3A1) as a common cause of intracranial aneurysms or cervical artery dissections: Results from sequence analysis of the coding sequences of type III collagen from 55 unrelated patients. Neurology 1993; 43: 2652-2658
24. St Jean P, Hart B, Webster M, et al. Alpha-1-antitrypsin deficiency in aneurysmal disease. Hum Hered 1996; 46: 92-97
25. Yoneyama T, Kasuya H, Akagawa H, et al. Absence of alpha-1 antitrypsin deficiency alleles (S and Z) in Japanese and Korea patients with aneurysmal subarachnoid hemorrhage. Stroke 2004; 35: e376
26. Yoon S, Tromp G, Vongpunsawad S, et al. Genetic analysis of MMP3, MMP9, and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms. Biochem Biophys Res Commun 1999; 265: 563-568
27. Zhang BP, Phillon S, Geary I, et al. Polymorphisms in matrix metalloproteinase-1, -3, -9, and -12 genes in relation to subarachnoid hemorrhage. Stroke 2001; 32: 2198-2202
28. Krex D, Kotteck K, Konig IR, et al. Matrix-metalloproteinase-9 coding sequence single-nucleotide polymorphisms in Caucasians with intracranial aneurysms. Neurosurgery 2004; 55: 207-212
29. Krex D, Rohl H, Konig IR, et al. Tissue inhibitor of metallopro-teinases-1, -2, and -3 polymorphisms in a white population with intracranial aneurysms. Stroke 2003; 34: 2817
30. Krex D, Ziegler A, Schackect HK, et al. Lack of association between endoglin intron 7 insertion polymorphism and intracranial aneurysms in a white population: Evidence of racial/ethnic differences. Stroke 2001; 32: 2689-2694
31. Onda H, Kasuya H, Yoneyama T, et al. Endoglin is not a major susceptibility gene for intracranial aneurysm among Japanese. Stroke 2003; 34: 1640-1644
32. Peters DG, Kassan AB, Chang YF. A DNA sequence polymorphism in the endoglin gene is not associated with intracranial aneurysms or aneurysmal subarachnoid hemorrhage. Cerebrovas Dis 2005; 20: 96-100
33. Onda H, Kasuya H, Yoneyama T, et al. Genomewide-linkage and haplotype-association studies map intracranial aneurysm to chromosome 7q11. Am J Hum Genet 2001; 69: 804-819
34. van der Voet M, Olson JM, Kuivaniemi H, et al. intracranial aneurysms in Finnish families: Confirmation of linkage and refinement of the interval to chromosome 19q13.3. Am J Hum Genet 2004; 74: 564-571
35. Roos YB, Pals G, Struycken PM, et al. Genome-wide linkage in a large Dutch consanguineous family maps a locus for intracranial aneurysm to chromosome 2q13. Stroke 2004; 35: 2276-2281
36. Nahed BV, Seker A, Guclu B, et al. Mapping a Mendelian form of intracranial aneurysm to 1p34.3-p36.13. Am J Hum Genet 2005; 76: 172-179
37. Ruigrok YM, Seitz U, Wotterink S, et al. Association of polymorphisms and haplotypes in the elastin gene in Dutch patients with subarachnoid hemorrhage from non-familial aneurysms. Stroke 2004; 35: 2064-2068
38. Yoneyama T, Kasuya H, Onha H, et al. Collagen type I alpha 2 (COL1A2) is the susceptible gene for intracranial aneurysms. Stroke 2004; 35: 443-448
39. van Alphen HA, Gao YZ, Kamphorst W. An acute experimental model of saccular aneurysms in the rat. Neurol Res 1990; 12: 256-259
40. Hsieh HJ, Li NQ, Frangos JA. Shear stress increases endothelial platelet-derived growth factor mRNA levels. Am J Physiol 1991; 260: H642-H646
41. Hsieh HJ, Li NQ, Frangos JA. Shear-induced platelet-derived growth factor gene expression in human endothelial cells is mediated by protein kinase C. J Cell Physiol 1992; 150: 552-558
42. Resnick N, Collins T, Atkinson W, et al. Platelet-derived growth factor B chain promoter contains a cis-acting fluid shear-stress-responsive element. Proc Natl Acad Sci USA 1993; 90: 4591-4595
43. Mitsumata M, Fishel RS, Nerem RM, et al. Fluid shear stress stimulates platelet-derived growth factor expression in endothelial cells. Am J Physiol 1993; 265: H3-H8
44. Linder V, Giachelli CM, Schwartz SM, et al. A subpopulation of smooth muscle cells in injured rat arteries expresses platelet-derived growth factor B chain mRNA. Circ Res 1995; 76: 951-957
45. Tanizawa S, Ueda M, van der Loos CM, et al. Expression of platelet-derived growth factor B chain and beta receptor in human coronary arteries after percutaneous transluminal coronary angioplasty: An immunochemical study. Heart 1996; 75: 549-556
46. Palumbo R, Gaetano C, Melillo G, et al. Shear stress down-regulation of platelet-derived growth factor receptor-beta and matrix metalloproteinase-2 is associated with inhibition of smooth muscle cell and migration. Circulation 2000; 102: 225-230
47. Fabunmi RP, Baker AH, Murray EJ, et al. Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors of metalloproteinases-1,-2 and -3 in rabbit aortic smooth muscle cells. Biochem J 1996; 315: 335-342
48. Cho A, Graves J, Reidy MA. Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2000; 20: 2527-2532